Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2013
09/26/2013WO2013052885A9 Prophylactic and post-acute use of progesterone in conjunction with its enantiomer for use in treatment of traumatic brain injuries
09/26/2013WO2013032558A3 Products for anti-inflammation support
09/26/2013WO2012159565A9 6-(aryl-carboxamide) imidazo [1,2-a] pyrimidine and 6-(aryl carboxamide) [1,2,4] triazolo [4,3-a] pyrimidine as hedgehog pathway inhibitor and use thereof
09/26/2013WO2012148540A8 Combination of kinase inhibitors and uses thereof
09/26/2013WO2012112232A8 METHODS AND COMPOSITIONS FOR TREATING β-THALASSEMIA AND SICKLE CELL DISEASE
09/26/2013WO2012085935A3 Diamide piperidine compounds as inhibitors of renin
09/26/2013WO2012028473A3 Cosmetic preparations having a calming effect
09/26/2013US20130253202 Method of treating hematological cancers
09/26/2013US20130253199 Polymorphic Forms of Naltrexone
09/26/2013US20130253196 Salts of prodrugs of piperazine and substituted piperidine antiviral agents
09/26/2013US20130253071 Methods and Compositions for Prevention and Treatment of Inflammatory Disease, Autoimmune Disease and Transplant Rejection
09/26/2013US20130253070 Combination of carotenoids and epi-lutein
09/26/2013US20130253069 Use of DMSO for Destroying Adipocytes and Eliminating Cellulite and Adiposities
09/26/2013US20130253068 Cosmetic or Dermatological Preparations Containing Licochalcone A or an Extract of Radix Glycyrrhizae inflatae, Containing Licochalcone A
09/26/2013US20130253067 Method of treating bladder disorders
09/26/2013US20130253066 Use of an S1P Receptor Agonist
09/26/2013US20130253065 Inhalable Epinephrine
09/26/2013US20130253062 Combinations of adapalene and benzoyl peroxide for treating acne lesions
09/26/2013US20130253060 Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences (NIEHS)
09/26/2013US20130253058 Satiety-inducing composition
09/26/2013US20130253056 Continuous Administration of Levodopa and/or Dopa Decarboxylase Inhibitors and Compositions for Same
09/26/2013US20130253052 Anti-cancer compositions and methods
09/26/2013US20130253050 Lipid raft, caveolin protein,, and caveolar function modulation compounds and associated synthetic and therapeutic methods
09/26/2013US20130253049 Treatment for pulmonary hypertension
09/26/2013US20130253048 Pharmaceutical Composition for Promoting Osteogenesis Containing Axial-equatorial Aryl-oriented Furofuran-type Lignan, and Pharmaceutical Preparation, Functional Food Product, and Health Food Product Comprising Composition
09/26/2013US20130253047 Method and composition for preventing and treating avian influenza in poultry
09/26/2013US20130253046 Methods of treating cancer comprising targeting nqo1
09/26/2013US20130253044 Taxane analogs for the treatment of brain cancer
09/26/2013US20130253041 Methods of Treating Neurodegenerative Disease
09/26/2013US20130253039 Colorectal cancer treatments and diagnostic improvements
09/26/2013US20130253035 Camkk-beta as a target for treating cancer
09/26/2013US20130253032 Use of Apoptosis-specific eIF-5A siRNA to Down Regulate Expression of Proinflammatory Cytokines to Treat Sepsis
09/26/2013US20130253031 Methods of treating mixed dyslipidemia
09/26/2013US20130253030 Methods of treating mixed dyslipidemia
09/26/2013US20130253029 Novel bicyclic compounds
09/26/2013US20130253027 Dosages of arylsulfonamide derivatives
09/26/2013US20130253026 Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration
09/26/2013US20130253025 Formulations of bendamustine
09/26/2013US20130253020 Treatment of Degenerative Disc Diseases
09/26/2013US20130253019 Lysophosphatidic acid receptor antagonists for the treatment of conditions or diseases of the eye
09/26/2013US20130253017 Methods of Delivering a Health Care Active by Administering Personal Health Care Articles Comprising a Filmament
09/26/2013US20130253015 Cyclodextrin-Based Microemulsions, and Dermatological Uses Thereof
09/26/2013US20130253014 Cyclodextrin-Based Microemulsions, and Dermatological Uses Thereof
09/26/2013US20130253005 Small molecule inhibitors of usp1 deubiquitinating enzyme activity
09/26/2013US20130253003 Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy
09/26/2013US20130253000 Treatment of solid tumors with rapamycin derivatives
09/26/2013US20130252998 Cci-779 formulations for parenteral administration
09/26/2013US20130252997 Treating unwanted ocular condition using an ascomycin macrolactam
09/26/2013US20130252996 Methods and kits for treating cluster headache disorders
09/26/2013US20130252995 Methods for reducing binge or compulsive eating
09/26/2013US20130252993 Tricyclic compound and use thereof
09/26/2013US20130252991 Combination
09/26/2013US20130252990 Stable pharmaceutical composition and methods of using same
09/26/2013US20130252989 Stable pharmaceutical composition and methods of using same
09/26/2013US20130252988 Compositions and methods for treating myelofibrosis
09/26/2013US20130252983 Activating phosphorylation site on glutaminase c
09/26/2013US20130252979 Pharmaceutical compositions, dosage forms and new forms of the compound of mula (i), and methods of use thereof
09/26/2013US20130252971 Ophthalmic Formulations of Cetirizine and Methods of Use
09/26/2013US20130252970 Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis
09/26/2013US20130252965 Combinations of serotonin receptor agonists for treatment of movement disorders
09/26/2013US20130252956 Methods of treating cancer
09/26/2013US20130252955 (aza)indole derivative and use thereof for medical purposes
09/26/2013US20130252952 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
09/26/2013US20130252947 BMP-2 Upregulating Compounds For Healing Bone Tissue And Screening Methods For Selecting Such Compounds
09/26/2013US20130252944 Novel fused pyrazole derivatives and their use as allosteric modulators of metabotropic glutamate receptors
09/26/2013US20130252942 Quinazoline carboxamide azetidines
09/26/2013US20130252940 c-Met Modulators and Method of Use
09/26/2013US20130252937 New indanyloxydihydrobenzofuranylacetic acids
09/26/2013US20130252934 Serine/threonine kinase inhibitors
09/26/2013US20130252933 Compositions for Delivering Perfume to the Skin
09/26/2013US20130252932 Localized modulation of tissues and cells to enhance therapeutic effects including renal denervation
09/26/2013US20130252929 Pharmaceutical composition including mometasone furoate and azelastine hydrochloride for nasal administration
09/26/2013US20130252928 Combinations comprising antimuscarinic agents and pde4 inhibitors
09/26/2013US20130252927 Treating conditions associated with increased eotaxin with 25-hydroxyvitamin d3
09/26/2013US20130252925 Pain relief compositions, manufacture and uses
09/26/2013US20130252924 Compounds and Methods for Treating Pain
09/26/2013US20130252923 Skin-beautifying agent
09/26/2013US20130252922 Substituted phenoxypyridines
09/26/2013US20130252921 Adhesion barrier containing hyaluronic acids and l-arginine
09/26/2013US20130252920 Pharmaceutical combinations comprising a thionucleotide analog
09/26/2013US20130252917 Combination therapy of 4-(3-(2h-1,2,3-triazo-2-yl)phenylamino)-2-((1r,2s)-2-aminocyclohexylamino)pyrimidine-5-carboxamide and fludarabine
09/26/2013US20130252913 18-Membered Macrocycles and Analogs Thereof
09/26/2013US20130252911 Compositions comprising flavonoid-containing extracts from plants of the genus citrus and/or isolated citrus flavonoids and specific cationic surface active agents, and said composition for use as an agent for treating infestations with head lice
09/26/2013US20130252908 Pharmaceutical composition, methods for treating and uses thereof
09/26/2013US20130252890 6,7-dihydro-5h-benzo[7]annulene derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and the use thereof for production of medicaments
09/26/2013US20130252886 Methods of delaying and treating diabetes
09/26/2013US20130252885 Fused tricyclic compounds as adenosine receptor antagonist
09/26/2013US20130252882 Antimicrobial 4-oxoquinolizines
09/26/2013US20130252879 Rapamycin formulation using recombinant high-density lipoprotein including apolipoprotein a-i and a mutant thereof
09/26/2013US20130252333 Modulators of ATP-Binding Cassette Transporters
09/26/2013US20130252331 Compositions and methods for modulating metabolism
09/26/2013US20130251996 Modified Starch Material of Biocompatible Hemostasis
09/26/2013US20130251818 Personal lubricants
09/26/2013US20130251815 Compositions and methods for oral delivery of encapsulated diethylenetriaminepentaacetate particles
09/26/2013US20130251814 Magnetic nanodrug for treating thrombosis
09/26/2013US20130251813 Formulation of lacosamide
09/26/2013US20130251812 Sequestered antagonist formulations
09/26/2013US20130251811 Method for manufacturing medicinal compounds containing dabigatran
09/26/2013US20130251810 Process for preparing orally administered dabigatran formulations
09/26/2013US20130251808 Pharmaceutical composition, method of preparation and methods of treating aches/pains
1 ... 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 ... 7860